Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-07-29
2000-10-17
Fonda, Kathleen K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 41, 536 172, 536 53, 536 55, 536 551, 514 54, 514 62, A61K 3170, C07H 1500
Patent
active
061332399
ABSTRACT:
An unbranched polylactosamine comprising at least 6 monosaccharides and having terminal .alpha.2.fwdarw.3 sialylation and internal .alpha.1.fwdarw.3 fucosylation at various N-acetylglucosamine residues except for solely at the penultimate N-acetylglucosamine residue.
REFERENCES:
patent: 4851511 (1989-07-01), Hakomori et al.
patent: 5011920 (1991-04-01), Hakomori et al.
patent: 5198424 (1993-03-01), McEver
patent: 5211936 (1993-05-01), Brandley et al.
patent: 5227369 (1993-07-01), Rosen et al.
patent: 5268364 (1993-12-01), Kojima et al.
patent: 5316913 (1994-05-01), Butcher et al.
patent: 5326752 (1994-07-01), Nashed et al.
patent: 5369017 (1994-11-01), Wong et al.
patent: 5369096 (1994-11-01), Yamada et al.
patent: 5412123 (1995-05-01), Rao et al.
patent: 5418129 (1995-05-01), Nudelman et al.
patent: 5426178 (1995-06-01), Laine et al.
European Search Report, dated Feb. 12, 1997, for EP 96 11 3074.
Alon et al., 1995, J. Immunol.. 154:5356-5366.
Asada et al., 1991, Biochem. 30:1561-1571.
Atkins et al., 1974, Polymer 15:263-271.
Berg et al., 1991, J. Biol. Chem. 266:14869-14872.
Fukada et al., 1979, J. Biol. Chem. 254:5458-5465.
Fukada et al., 1984, J. Biol. Chem. 259:10925-10935.
Fukushi et al., 1984, J. Biol. Chem. 259:10511-10517.
Fukushima et al., 1984, Cancer Res. 44:5279-5285.
Handa et al., 1991, Biochem. Biophys. Res. Comm. 181:1223-1230.
Handa et al., 1995, Int. J. Oncol. 6:773-781.
Ito et al., 1994, Glycoconj. J. 11:232-237.
L.A. Lasky, 1995, Ann. Rev. Biochem. 64:113-139.
Lawrence et al., 1987, Blood 70:1284-1290.
Lawrence et al., 1990, Blood 75:227-237.
Lawrence & Springer, 1991, Cell 65:859-873.
Lowe et al., 1991, J. Biol. Chem. 266:17467-17477.
Macher et al., 1988, J. Biol. CHem. 263:10186-10191.
Mulligan et al., 1993, J. Exp. Med. 178:623-631.
Muroi et al., 1992, Blood 79:713-719.
Niemann et al., 1978, Biochem. Biophys. Res. Comm. 81:1286-1293.
Nudelman et al., 1988, J. Biol. Chem. 263:13942-13951.
Osanai et al., 1996, Biochem. Biophys. Res. Comm. 218:610-615.
Patel et al., 1994, Biochem. 33:14815-14824.
Phillips et al., 1990, Science 250:1130-1132.
Polley et al., 1991, PNAs USA 88:6224-6228.
Rees et al., 1975, MTP International Rev. of Science, W.J. Whelan, ed., Butterworths (London), Univ. Park Press (Baltimore) 5:1-42.
Sako et al., 1993, Cell 75:1179-1186.
Stroud et al., Apr. 26, 1995, Biochem. Biophys. Res. Comm. 209:777-787.
Stroud et al., 1996, Biochem. 35:758-769.
Stroud et al., 1996, Biochem. 35:770-778.
Takada et al., 1991, Biochem. Biophys. Res. Comm. 179:713-719.
Tiemeyer et al., 1991, PNAS USA 88:1138-1142.
Tyrrell et al., 1991, PNAS USA 88:10372-10376.
A. Varki, 1994, PNAS USA 91:7390-7397.
Walz et al., 1990, Science 250:1132-1135.
Yang & Hakomori, 1971, J. Biol. Chem. 246:1192-1200.
Hakomori Sen-itiroh
Handa Kazuko
Salyan Mary Ellen K.
Stroud Mark R.
Fonda Kathleen K.
Seikagaku Corporation
The Biomembrane Institute
LandOfFree
Carbohydrate ligands (myelorollin) that cause E-selectin depende does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbohydrate ligands (myelorollin) that cause E-selectin depende, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbohydrate ligands (myelorollin) that cause E-selectin depende will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-468948